← Eichor
Study identifier: NCT04687956 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Primary Surgical Prevention of Breast Cancer-related Lymphedema

Condition: Lymphedema · Mastectomy · Breast Cancer  ·  Sponsor: Gangnam Severance Hospital

PhaseNA
Planned participants72
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

Lymphedema refers to edema caused by insufficient drainage of interstitial fluid through the lymphatic circulation system. It occurs mainly in the upper and lower extremities and causes chronic inflammation, and finally fibrous adipose tissue is replaced. In this study, the'LYMPHA' (Lymphatic microsurgical preventing healing approach) procedure, which connects lymphatic vessels drained from the arm to the side branches of the axillary vein, contributes to the prevention of lymphedema in patients undergoing axillary lymph node dissection for breast cancer. Investigator aim to help patients' quality of life by prospectively analyzing the effects and applying them to clinical practice, reducing the incidence of lymphedema.

This description comes directly from the study's public registry record.

Talk to the study team

Soong June Bae, M.D.  ·  82-2-2019-4401  ·  mission815815@yuhs.ac

Always discuss trial participation with your own doctor first.

Locations (1)

Gangnam Severance Hospital, Yonsei University College of MedicineSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04687956